OAR 845-025-7080: Cannabinoid Topical Labeling Requirements
Edition: Current OARD snapshotEffective: 2022-03-25Last verified: 2026-09-07
Prior to a cannabinoid topical product being sold or transferred to a consumer, patient or designated primary caregiver the container holding the cannabinoid product must have a label that has the following information: (1) Processor’s business or trade name and license number; (2) Business or trade name of licensee that packaged the product, if different from the processor; (3) UID number; (4) Product identity; (5) Date the product was made; (6) Net weight or volume in U.S. customary and metric units; (7) Amount suggested for use by the consumer or patient at any one time; (8) Concentration of THC and CBD in the container (%); (9) List of ingredients in descending order of predominance by weight or volume used to process the cannabinoid topical; (10) Name of the lab that performed any test and any test analysis date; (11) Universal symbol; (12) A statement that reads: “This product is not approved by the FDA to treat, cure, or prevent any disease”; (13) For cannabinoid topicals for sale to a consumer, warnings that state: (a) “For use only by adults 21 and older. Keep out of reach of children.” (b) “DO NOT EAT” in bold, capital letters.
Official history and status
Statutory/Other Authority: ORS 475C.604
Statutes/Other Implemented: ORS 475C.604
History: OLCC 150-2022, minor correction filed 03/25/2022, effective 03/25/2022 OLCC 6-2018, adopt filed 05/23/2018, effective 06/01/2018
This rule cites
No citations extracted.
Cited by
Official source: https://secure.sos.state.or.us/oard/